BIOG vs. BGSC, ESCT, SDP, GSCT, VOF, CGI, SLS, USA, TRG, and APAX
Should you be buying The Biotech Growth Trust stock or one of its competitors? The main competitors of The Biotech Growth Trust include BMO Global Smaller Companies (BGSC), The European Smaller Companies Trust (ESCT), Schroder Investment Trust - Schroder AsiaPacific Fund (SDP), The Global Smaller Companies Trust (GSCT), VinaCapital Vietnam Opp Fund (VOF), Canadian General Investments (CGI), Standard Life UK Smaller Companies Trust (SLS), Baillie Gifford US Growth (USA), The European Smaller Companies Trust (TRG), and Apax Global Alpha (APAX). These companies are all part of the "asset management" industry.
The Biotech Growth Trust vs.
The Biotech Growth Trust (LON:BIOG) and BMO Global Smaller Companies (LON:BGSC) are both small-cap financial services companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, media sentiment, valuation, community ranking and institutional ownership.
The Biotech Growth Trust has higher earnings, but lower revenue than BMO Global Smaller Companies. BMO Global Smaller Companies is trading at a lower price-to-earnings ratio than The Biotech Growth Trust, indicating that it is currently the more affordable of the two stocks.
The Biotech Growth Trust received 67 more outperform votes than BMO Global Smaller Companies when rated by MarketBeat users. However, 68.18% of users gave BMO Global Smaller Companies an outperform vote while only 64.06% of users gave The Biotech Growth Trust an outperform vote.
The Biotech Growth Trust has a net margin of 95.33% compared to BMO Global Smaller Companies' net margin of 0.00%. The Biotech Growth Trust's return on equity of 26.96% beat BMO Global Smaller Companies' return on equity.
28.6% of The Biotech Growth Trust shares are owned by institutional investors. 0.7% of The Biotech Growth Trust shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
In the previous week, The Biotech Growth Trust's average media sentiment score of 0.00 equaled BMO Global Smaller Companies'average media sentiment score.
Summary
The Biotech Growth Trust beats BMO Global Smaller Companies on 7 of the 10 factors compared between the two stocks.
Get The Biotech Growth Trust News Delivered to You Automatically
Sign up to receive the latest news and ratings for BIOG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
The Biotech Growth Trust Competitors List
Related Companies and Tools
This page (LON:BIOG) was last updated on 5/23/2025 by MarketBeat.com Staff
